Bhagiradha Chemicals Reports Mixed Q2 Results: Revenue Up, EBITDA Down
Bhagiradha Chemicals & Industries Limited (BCIL) reported Q2 results with consolidated revenue increasing 35% YoY to ₹14,009.72 crore. Net profit slightly rose to ₹550.43 crore. However, EBITDA declined 84% to ₹15.5 crore. EBITDA margin improved to 10.75%. The company fully utilized ₹341.18 crore from a preferential issue for capital expenditure. BCIL's capital work in progress stood at ₹37,736.36 crore, indicating ongoing expansion efforts.

*this image is generated using AI for illustrative purposes only.
Bhagiradha Chemicals & Industries Limited (BCIL) has reported a mixed set of financial results for the second quarter. The agrochemical company saw an increase in revenue but experienced a significant decline in EBITDA compared to the same period last year.
Revenue Growth
BCIL reported a consolidated revenue from operations of ₹14,009.72 crore for Q2, marking a substantial increase from ₹10,372.80 crore in the corresponding quarter of the previous year. This represents a year-on-year growth of approximately 35%.
Profit and EBITDA Performance
The company's consolidated net profit for the quarter stood at ₹550.43 crore, slightly higher than the ₹544.09 crore reported in the same quarter of the previous year. However, BCIL experienced a significant decline in its EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization). The EBITDA for Q2 was reported at ₹15.5 crore, down from ₹97.1 crore in the same quarter of the previous year, marking a substantial decrease of about 84%.
EBITDA Margin
Despite the sharp decline in EBITDA, the company's EBITDA margin showed improvement. The EBITDA margin for Q2 increased to 10.75% from 9.36% in the corresponding quarter of the previous year.
Financial Position
As of September 30, Bhagiradha Chemicals reported the following key financial metrics:
| Particulars | Amount (in crore) |
|---|---|
| Total Assets | 96,168.99 |
| Total Equity | 68,945.31 |
| Non-Current Liabilities | 14,438.40 |
| Current Liabilities | 20,785.28 |
Capital Expenditure and Expansion
The company has been actively investing in its growth. BCIL reported significant capital work in progress, amounting to ₹37,736.36 crore as of September 30. This substantial investment indicates the company's focus on expanding its manufacturing capabilities and infrastructure.
Utilization of Preferential Issue Proceeds
In a notable development, Bhagiradha Chemicals has fully utilized the proceeds from its preferential issue of convertible warrants. The company raised a total of ₹341.18 crore through this issue, which has been completely deployed for the approved objectives, including funding capital expenditure for a new manufacturing unit under its wholly-owned subsidiary, Bheema Fine Chemicals Private Limited.
Conclusion
Bhagiradha Chemicals' Q2 results present a mixed picture. While the company has achieved significant revenue growth, the sharp decline in EBITDA may be a concern for investors. However, the improvement in EBITDA margin and substantial investments in capital expenditure indicate the company's efforts to enhance its operational efficiency and manufacturing capabilities for future growth.
Investors and market analysts will likely keep a close watch on how these investments translate into financial performance in the coming quarters, particularly in terms of profitability and margin expansion.
Historical Stock Returns for Bhagiradha Chemicals & Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.17% | -5.53% | -4.96% | -21.17% | -31.64% | -87.98% |

































